Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Branded and Biosimilar Ophthalmology

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

This public procurement record has 2 releases in its history.

Award

24 Nov 2025 at 16:57

Award Notice
Tender

06 Aug 2025 at 12:10

Tender Notice
Summary of the contracting process

The public procurement process conducted by The Common Services Agency, commonly known as NHS National Services Scotland (NSS), focuses on the supply of branded and biosimilar ophthalmology products. It falls under the pharmaceutical industry category and is aimed at NHS Scotland. The process pertains to a range of goods including Aflibercept, Ranibizumab, and Faricimab. The procurement method adopted for this process is an open procedure, and as of 24th November 2025, the procurement stage is at the award phase. The procurement includes a framework agreement with potential extensions. The entire contract, with all its lots, is in the region of UKM, covering all entities under the National Health Service (Scotland) Act 1978. Key dates include the signing of contracts on 30th October 2025, with the award period having commenced on 5th September 2025.

This tender presents significant opportunities for businesses involved in the pharmaceutical supply chain, especially those specialising in ophthalmology products. Companies with solid logistics arrangements and competitive pricing strategies could thrive under this framework agreement. Larger pharmaceutical enterprises, like Bayer Plc, as well as SMEs such as Mercury Pharmaceuticals Limited, have already been successful in securing contracts, indicating a range of opportunities for both large and small businesses. The framework supports collaborative engagement through NHS Scotland's Community Benefits Gateway, making this tender an appealing prospect for companies seeking to enhance their business presence in public healthcare procurement and contribute positively to community development initiatives.

How relevant is this notice?

Notice Information

Notice Title

Branded and Biosimilar Ophthalmology

Notice Description

Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.

Lot Information

Aflibercept (Eylea(r))

Supply of Aflibercept (Eylea(r)) vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as a single supplier framework to a single Framework Participant.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Aflibercept Biosimilar

Supply of Aflibercept Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to five (5) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Ranibizumab vials and Pre-filled Syringes

Supply of Ranibizumab Branded and Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Faricimab (Vabysmo(r))

Supply of Faricimab vials and Pre-filled Syringes to NHS Scotland. The Authority has not awarded this Framework to any suppliers.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-058262
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/076640-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£146,579,216 £100M-£1B
Lots Value
£146,579,217 £100M-£1B
Awards Value
Not specified
Contracts Value
£20,671,084 £10M-£100M

Notice Dates

Publication Date
24 Nov 20259 months ago
Submission Deadline
5 Sep 2025Expired
Future Notice Date
Not specified
Award Date
30 Oct 202510 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active, Unsuccessful
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
7
Supplier Names

Bayer Plc

Biogen Idec Ltd

Celltrion Healthcare United Kingdom Limited

MD Biologics

Mercury Pharmaceuticals Limited

Sandoz

Teva UK Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...